טוען...
Vitamin K antagonists versus antiplatelet therapy after transient ischaemic attack or minor ischaemic stroke of presumed arterial origin
BACKGROUND: People who have had a transient ischaemic attack (TIA) or non‐disabling ischaemic stroke have an annual risk of major vascular events of between 4% and 11%. Aspirin reduces this risk by 20% at most. Secondary prevention trials after myocardial infarction indicate that treatment with vita...
שמור ב:
| הוצא לאור ב: | Cochrane Database Syst Rev |
|---|---|
| Main Authors: | , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
John Wiley & Sons, Ltd
2012
|
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7055052/ https://ncbi.nlm.nih.gov/pubmed/22972051 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD001342.pub3 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|